Refeyn is pioneering the next era of molecular analysis with mass photometry, a breakthrough technology that weighs individual molecules with light. Our instruments deliver rapid, direct insights into biomolecular function and structure, accelerating discovery and transforming biotherapeutic development. With 1200+ citations, 600+ global installations, and use in Nobel Prize–winning research, Refeyn is shaping the future of scientific innovation.
| Website | https://www.refeyn.com |
| Revenue | $23.4 million |
| Employees | 169 (144 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+32 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Life Science |
| Keywords | Molecular Interactions, Protein Characterization, Biotechnology Instrumentation, Biomolecular Analysis, Pharmaceutical Analysis, Life Science Tools, Biotechnology Research, Biopharmaceutical Analysis, Analytical Instruments, Nanoparticle Characterization, Drug Discovery Tools |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, ZEISS Group, Bruker, Malvern Panalytical, Asylum Research, an Oxford Instruments Company, Molecular Devices, Sierra Instruments, BioVision, Nikon Instruments UK +30 more (view full list) |
Looking for a particular Refeyn employee's phone or email?
The Refeyn annual revenue was $23.4 million in 2026.
Fiona Coats is the CMO of Refeyn.
144 people are employed at Refeyn.